High-risk Pulmonary Embolism: Should We Be Less Patient with Thrombolytic Therapy?
Intern Med
.
2017;56(24):3407.
doi: 10.2169/internalmedicine.8202-16.
Epub 2017 Dec 15.
Authors
Fatma Yıldırım
1
,
Abdullah Özer
2
Affiliations
1
Department of Pulmonary and Critical Care Medicine, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Turkey.
2
Department of Cardiovascular Surgery, School of Medicine, Gazi University, Turkey.
PMID:
29249767
PMCID:
PMC5790740
DOI:
10.2169/internalmedicine.8202-16
No abstract available
Keywords:
high-risk pulmonary embolism; thrombolytic therapy; timing.
Publication types
Letter
Comment
MeSH terms
Fibrinolytic Agents
Humans
Pulmonary Embolism*
Thrombolytic Therapy*
Substances
Fibrinolytic Agents